These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38029005)

  • 1. Proton versus photon radiotherapy for hepatocellular carcinoma: Current data and technical considerations.
    Roberts HJ; Hong TS
    J Radiosurg SBRT; 2023; 9(1):9-16. PubMed ID: 38029005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
    Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.
    Cheng JY; Liu CM; Wang YM; Hsu HC; Huang EY; Huang TT; Lee CH; Hung SP; Huang BS
    Radiat Oncol; 2020 Jun; 15(1):159. PubMed ID: 32605627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.
    Hasan S; Abel S; Verma V; Webster P; Arscott WT; Wegner RE; Kirichenko A; Simone CB
    J Gastrointest Oncol; 2019 Oct; 10(5):999-1009. PubMed ID: 31602338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
    Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
    J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent update of proton beam therapy for hepatocellular carcinoma: A systematic review and meta-analysis.
    Bae SH; Jang WI; Mortensen HR; Weber B; Kim MS; Høyer M
    J Liver Cancer; 2024 Jul; ():. PubMed ID: 38961722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
    Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
    Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.
    Lee SU; Kim TH
    Clin Mol Hepatol; 2023 Oct; 29(4):958-968. PubMed ID: 37822213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma.
    Tsai YL; Takei H; Iizumi T; Okumura T; Sekino Y; Numajiri H; Ishikawa H; Sakae T; Sakurai H
    J Radiat Res; 2021 Jan; 62(1):133-141. PubMed ID: 33392617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
    Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
    Yoo GS; Yu JI; Park HC
    World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
    Bush DA; Volk M; Smith JC; Reeves ME; Sanghvi S; Slater JD; deVera M
    Cancer; 2023 Nov; 129(22):3554-3563. PubMed ID: 37503907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy for liver cancers.
    Chuong M; Kaiser A; Molitoris J; Mendez Romero A; Apisarnthanarax S
    J Gastrointest Oncol; 2020 Feb; 11(1):157-165. PubMed ID: 32175119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
    Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
    Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma.
    Abousaida B; Seneviratne D; Hoppe BS; Ko SJ; Asaithamby A; Cucinotta FA; Kirwan JM; Mody K; Toskich B; Ashman JB; Hallemeier CL; Krishnan S
    J Hepatocell Carcinoma; 2021; 8():1169-1179. PubMed ID: 34595139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
    Apisarnthanarax S; Bowen SR; Combs SE
    Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.